AJMC news story
For years, HIV has been synonymous not only with chronic infection but also with the specter of accelerated immune aging — an assumption that long-term damage to the immune system was inevitable, even in the era of effective treatment. But new data presented at CROI 2026 suggest a far more hopeful narrative: in people living with HIV on decades of antiretroviral therapy, the immune system may be more resilient — and even more adaptable — than previously believed.
The research examined how sustained viral suppression over 25 to 30 years reshapes HIV-specific CD8⁺ T-cell responses, offering fresh insight into immune reconstitution and the long-term prospects for HIV remission.
Read the full news story here.
View all AJMC reports from CROI 2026
Source : AJMC
Related HIV and Co-Infections News
-
Infectious Disease Advisor: Real-world data support switch to doravirine-based ART: HIV-1 control and QOL
-
NIH-funded breakthrough shrinks CRISPR for precision delivery in the body
-
University of Manchester: Scientists develop a cheaper and more sustainable way to manufacture breakthrough HIV drug lenacapavir
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.